PPP1R14B and cancer: Understanding the causes of PHI-1 up- or downregulation, its underlying mechanisms in tumor progression, and its impact on therapy resistance could uncover novel clinical benefits, including potential biomarkers for prognosis and new targets for cancer treatment.